XML 27 R2.htm IDEA: XBRL DOCUMENT v3.10.0.1
CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) - USD ($)
$ in Millions
Jun. 30, 2018
Dec. 31, 2017
Current assets:    
Cash and cash equivalents $ 202 $ 336
Investments 29 0
Restricted cash, cash equivalents and investments 629 1,280
Worksite employee related assets:    
Unbilled revenue (net of advance collections of $14 and $12 at June 30, 2018 and December 31, 2017, respectively) 268 297
Accounts receivable 7 20
Prepaid insurance premiums and other insurance related receivables 28 26
Other payroll assets 49 17
Worksite employee related assets 352 360
Prepaid expenses and other current assets 37 15
Total current assets 1,249 1,991
Investments, noncurrent 133 0
Restricted cash and available for sale investments 179 162
Workers' compensation collateral receivable 40 39
Property and equipment, net 79 70
Goodwill and other intangible assets, net 312 315
Other assets 23 16
Total assets 2,015 2,593
Current liabilities:    
Accounts payable and other current liabilities 39 59
Accrued corporate wages 35 40
Notes payable 21 40
Worksite employee related liabilities:    
Accrued wages 269 289
Client deposits 28 52
Payroll tax liabilities and other payroll withholdings 442 1,034
Health benefits loss reserves (net of prepayments of $38 and $19 at June 30, 2018 and December 31, 2017, respectively) 138 151
Workers' compensation loss reserves (net of collateral paid of $5 and $6 at June 30, 2018 and December 31, 2017, respectively) 67 67
Insurance premiums and other payables 22 25
Worksite employee related liabilities 966 1,618
Total current liabilities 1,061 1,757
Notes payable, noncurrent 402 383
Workers' compensation loss reserves (net of collateral paid of $XX and $6 at March 31, 2018 and December 31, 2017, respectively) 157 165
Deferred income taxes 70 68
Other liabilities 16 14
Total liabilities 1,706 2,387
Commitments and contingencies (see Note 9)  
Stockholders’ equity:    
Preferred stock ($0.000025 par value per share; 20,000,000 shares authorized; no shares issued and outstanding at March 31, 2018 and December 31, 2017) 0 0
Common stock and additional paid-in capital ($0.000025 par value per share; 750,000,000 shares authorized; 70,363,251 and 69,818,392 shares issued and outstanding at March 31, 2018 and December 31, 2017, respectively) 611 583
Accumulated deficit (302) (377)
Total stockholders’ equity 309 206
Total liabilities and stockholders’ equity $ 2,015 $ 2,593